Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor

Infection and Immunity

Volumn 70, Issue 7, 2002, Pages 3576-3585

  Achour, Y Ben ^a   Chenik, M ^a   Louzir, H ^a   Dellagi, K ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; DISULFIDE ISOMERASE; DISULFIDE ISOMERASE INHIBITOR; ISOMERASE; ISOMERASE INHIBITOR; PROTEIN LMPDI; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DISEASE SEVERITY; DNA MODIFICATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; GENE ISOLATION; LEISHMANIA MAJOR; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PARASITE VIRULENCE; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BACITRACIN; BASE SEQUENCE; CLONING, MOLECULAR; DITHIONITROBENZOIC ACID; DNA, PROTOZOAN; ENZYME INHIBITORS; GENE EXPRESSION; GENES, PROTOZOAN; HUMANS; LEISHMANIA MAJOR; MOLECULAR SEQUENCE DATA; PROTEIN DISULFIDE-ISOMERASE; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; VIRULENCE;

EID: 0036087747     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.7.3576-3585.2002     Document Type: Article

References (58)

1. The interaction of Leishmania species with macrophages
2. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response
3. Overexpression of miniexon gene decreases virulence of Leishmania major in BALB/c mice in vivo
4. Building bridges: Disulphide bond formation in the cell
5. Lipophosphoglycan LPG and the identification of virulence genes in the protozoan parasite Leishmania
6. Identification of genes mediating lipophosphoglycan biosynthesis by functional complementation of Leishmania donovani mutants
7. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: A possible role of virulence molecules gp63 and LPG
8. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63
9. Infectivity and attenuation of Leishmania donovani promastigotes: Association of galactosyl transferase with loss of parasite virulence
10. A specialized pathway affecting virulence glycoconjugates of Leishmania
11. Survival strategies of Leishmania donovani in mammalian host macrophages
12. Leishmaniasis. Public health aspects and control
13. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages
14. The protein disulphide-isomerase family: Unravelling a string of folds
15. The role of phosphomannose isomerase in Leishmania mexicana glycoconjugate synthesis and virulence
16. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability
17. Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite
18. Pilus and nonpilus bacterial adhesins: Assembly and function in cell recognition
19. Proteophosphoglycans of Leishmania
20. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice
21. Bifunctional thymidylate synthasedihydrofolate reductase in protozoa
22. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response
23. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan
24. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
25. Analysis of altered gene expression by differential display
26. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
27. Immunological determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major
28. Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: Pre-steady-state kinetics and the utilization of the oxidizing equivalents of the isomerase
29. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase
30. Phenotypic changes associated with deletion and overexpression of a stage-regulated gene family in Leishmania
31. Roles of free GPIs in amastigotes of Leishmania
32. Purification and characterization of yeast protein disulfide isomerase
33. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions
34. Reduced expression of lipophosphoglycan LPG and kinetoplastid membrane protein KMP-11 in Leishmania donovani promastigotes in axenic culture
35. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major
36. Cloning, characterization and overexpression of two iron superoxide dismutase cDNAs from Leishmania chagasi: Role in pathogenesis
37. Characterization of a periplasmic thio: Disulfide interchange protein required for the functional maturation of secreted virulence factors of Vibrio cholerae
38. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
39. Bacitracin: An inhibitor of the insulin degradating activity of glutathione-insulin transhydrogenase
40. Inhibition of human immunodeficiency virus infection by agents that interfere with thio-disulfide interchange upon virus-receptor interaction
41. The role of phosphoglycans in Leishmania-sand fly interactions
42. Differential expression of stress proteins in virulent and attenuated promastigotes of Leishmania donovani
43. Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
44. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
45. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major
46. Genomic organisation, transcription, splicing and gene regulation in Leishmania
47. Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms
48. The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation
49. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus
50. Molecular aspects of complement-mediated bacterial killing. Periplasmic conversion of C9 from a protoxin to a toxin
51. A mitogen-activated protein MAP kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host
52. Control of the leishmaniasis
53. DsbA: A protein-folding catalyst contributing to bacterial virulence
54. Inactivation of DsbA, but not DsbC and DsbD, affects the intracellular survival and virulence of Shigella flexneri
55. Key role for DsbA in cell-to-cell spread of Shigella flexneri, permitting secretion of Ipa proteins into interepithelial protrusions
56. A homologue of the Escherichia coli DsbA protein involved in disulphide bond formation is required for enterotoxin biogenesis in Vibrio cholerae
57. DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli
58. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2